Unique Noninvasive Solution Sommetrics' aer+ technology uses negative pressure to hold the airway open in a comfortable, noninvasive way, providing a distinguishing option for patients who cannot tolerate CPAP and for airway management during procedures.

Regulatory Momentum FDA Breakthrough Device designation, along with ongoing aerSleep II clinical efforts, signals strong regulatory and clinical validation that can accelerate market access and payer discussions.

Commercial Readiness Leadership and advisor appointments, including a former Inogen CEO joining the board and a dedicated commercialization advisor, indicate a deliberate push to scale sales, market development, and strategic partnerships.

Target Markets Key sales opportunities exist with obstructive sleep apnea patients seeking alternatives to CPAP and with hospitals and sleep clinics requiring reliable airway management solutions during procedures.

Partnerships & Credibility Industry recognition, including Frost & Sullivan award and a strategic board, enhances credibility to recruit distributors, clinician advocates, and payer partners to accelerate adoption.